Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Next-Gen Anticoagulant Lands FDA Nod for Secondary Stroke Prevention

(MedPage Today) -- The FDA approved asundexian (Sunharbo) as the first factor XIa (FXIa) inhibitor for secondary stroke prevention, the agency announced on Monday. Asundexian, an oral, direct, small-molecule inhibitor of FXIa, is indicated for...

Next-Gen Anticoagulant Lands FDA Nod for Secondary Stroke Prevention

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 10 November →